First Heartland Consultants’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-4,548
Closed -$472K – 386
2023
Q1
$472K Buy
4,548
+1,046
+30% +$116K 0.07% 205
2022
Q4
$404K Buy
+3,502
New +$408K 0.07% 231

Other funds holding MED

First Heartland Consultants's MED Position: Q2 2023 in Review

First Heartland Consultants sold out of Medifast (MED) in Q2 2023, closing a stake of 4,548 shares — an estimated $472K sold.

First Heartland Consultants first reported a position in MED in Q4 2022 and held it in 2 quarters. The position peaked at $472K in Q1 2023. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • First Heartland Consultants reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • First Heartland Consultants sold 4,548 Medifast shares in Q2 2023, an estimated $472K.
  • First Heartland Consultants first reported a position in Medifast in Q4 2022 and held it in 2 quarters.
  • First Heartland Consultants's Medifast position peaked at $472K in Q1 2023.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on First Heartland Consultants's 13F filing for Q2 2023, filed 26 Jul 2023.